CompletedNot Applicable

The Predictive Value of Coronary Artery Calcium Score

Iran498 participantsStarted 2022-01-01

Plain-language summary

In this analytical prospective study 498 patients over 40 years with any cardiovascular symptoms and without pre-established coronary artery disease ( CAD) were enrolled. Patients underwent CT scans to measure coronary artery calcium score (CACS), and total calcium scores were recorded. Then, conventional coronary angiography was performed for all the participants as the gold standard for diagnosing CAD (defined as at least one stenotic coronary artery with ≥ 50%). Framingham risk score (FRS) was also estimated for all the patients

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age over 40 years, having cardiovascular symptoms (including chest pain, dyspnea on exertion, etc.), and positive primary non-invasive tests, such as myocardial perfusion imaging (MPI) or exercise tolerance test (ETT) Exclusion Criteria: * Previously diagnosed coronary artery disease * Cerebrovascular accident (CVA) * Peripheral artery disease * Pregnancy * Medical instability * Hypersensitivity to contrast materials * Having atrial fibrillation

What they're measuring

coronary artery disease

Timeframe: 1 year

coronary calcium score

Timeframe: 1 year

Trial details

NCT IDNCT06311071

SponsorShiraz University of Medical Sciences

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-05-01

View on ClinicalTrials.gov More Coronary Artery Disease trials